CLOs on the Move

University of Texas at Dallas

www.utdallas.edu

 
The University of Texas at Dallas is an innovative institution in the heart of North Texas on the path to achieving Tier One national research university status. UT Dallas has grown since its founding in 1969 to include 133 degree programs, with cutting-edge curricula serving a variety of undergraduate and graduate student interests
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.utdallas.edu
  • 800 W. Campbell Road
    Richardson, TX USA 75080
  • Phone: 972.883.2111

Executives

Name Title Contact Details
Sanaz Okhovat
Associate Vice President for Research and Chief Compliance Officer Profile
Jody Nelsen
Associate VP for Business Affairs Profile

Similar Companies

University of Massachusetts Dartmouth

Offering undergraduate, graduate programs, and doctoral programs, UMass Dartmouth provides world-class education to nearly 9,000 students a year who pursue the questions about their future.

Whitworth University

Since 1890, Whitworth has held fast to its founding mission to provide "an education of mind and heart" through rigorous intellectual inquiry guided by dedicated Christian scholars. Recognized as one of the top regional colleges and universities in the West, Whitworth University has an enrollment of 3,000 students and offers 60 undergraduate and graduate degree programs. In recent years, Whitworth has enjoyed record levels of student enrollment and retention, the strongest financial position in the university`s history, and increased external visibility.

Goodwin College

Goodwin College is a East Hartford, CT-based company in the Education sector.

Southwest Michigan Library Coop

Southwest Michigan Library Coop is a Paw Paw, MI-based company in the Education sector.

HistoSonics

HistoSonics Inc. is a new medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue excision technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia (BPH), a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.